Abyak Pharma Ltd Pharmaceutical Import Profile — Ghana (DGFT 2022–2026)

Name: Abyak Pharma Ltd Pharmaceutical Import Records from India — 2 Products, $3.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Abyak Pharma Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $3.0M Trade | TransData Nexus

Abyak Pharma Ltd

Pharmaceutical Importer · Ghana · Respiratory & OTC Focus · $3.0M Total Trade · DGFT Verified

Abyak Pharma Ltd is a pharmaceutical importer based in Ghana with a total trade value of $3.0M across 2 products in 2 therapeutic categories. Based on 114 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Abyak Pharma Ltd sources from 2 verified Indian suppliers, with Socomed Pharma Private Limited accounting for 83.6% of imports.

Abyak Pharma Ltd — Import Portfolio & Supplier Network

Abyak Pharma Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Abyak Pharma Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Socomed Pharma Private Limited	$4.2M	161	83.6%
Xl Laboratories Private Limited	$824.3K	42	16.4%

Abyak Pharma Ltd sources from 2 verified Indian suppliers across .

What Formulations Does Abyak Pharma Ltd Import?

Formulation	Value	Ships
Other: peladol extra (paracetamol 325 MG	$277.8K	10
Other: peladol extra (paracetamol	$243.5K	5
Other: peladol extra forte capsules	$81.2K	2
Other paracetamol 325 MG diclofenacsodium 50 MG caffeine 30 MG tablets peladol extra pieces packs of 20x1x10s	$78.3K	2
Hycid-20 (omeprazole capsules 20MG)batchno. d819,d820,d821,d822,d823 mfg.dt.04/2024,exp.dt.10/2026	$76.6K	3
Other: paracetamol 500 MG + caffeine 25MG + phenylephrine hydrochloride 2.5 MG+ chlorpheniramine maleate 2 MG	$76.5K	3
Hycid -20(omeprazole capsules 20MG) eachcap.cont.omeprazole BP 20MG,b/no. d693to d697 m/dt.12/23	$76.2K	3
Other: cyproheptadine with b-complex syrup abytone forte syrup (pieces - packs of 200 ML bottle)	$62.5K	2
Other: abyco capsules cyproheptadine with b-complex capsules pieces - packs of 10x1x30s	$50.8K	2
Other: cyproheptadine with multivitamincapsules abytone forte capsules (pieces- packs of 10 x 3 x 10s capsules)	$50.8K	2
Other: cyproheptadine with multivitamintablets abytone tablets (pieces - packsof 25 x 1 x 20s tablets)	$50.4K	2
Other: cyproheptadine with multivitamincapsules abytone forte capsules (pieces- packs of 10x3x10s capsules)	$50.2K	2
Hycid-20(omeprazole capsules 20MG	$50.0K	1
Other: abytone tablets (cyproheptadine	$50.0K	1
Other : peladol extra (paracetamol 325	$50.0K	1

Abyak Pharma Ltd imports 164 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Caffeine	Respiratory & OTC	$2.5M	95	2.3%	6
2	Chlorpheniramine	Antihistamines & Allergy	$497.1K	19	1.1%	7

Abyak Pharma Ltd imports 2 pharmaceutical products across 2 categories into Ghana totaling $3.0M.

Abyak Pharma Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Abyak Pharma Ltd is a pharmaceutical importer and distributor based in Kumasi, Ghana. Established to meet the growing demand for quality pharmaceutical products, the company specializes in sourcing and supplying finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its strategic location in Kumasi positions it as a key player in the Ashanti Region's healthcare supply chain. The company operates independently, without a publicly known parent organization, and plays a significant role in ensuring the availability of essential medications across Ghana.

2Distribution Network

Abyak Pharma Ltd's distribution network is centered in Kumasi, with its primary warehouse located at Kwabena Asamoah Street, Tafo, Ashanti Region. This central location facilitates efficient logistics and timely delivery of pharmaceutical products throughout the region. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the company's operations are designed to ensure a steady supply of medications to meet the needs of healthcare providers and patients across Ghana.

3Industry Role

In Ghana's pharmaceutical supply chain, Abyak Pharma Ltd functions as a primary wholesaler and distributor. By importing finished pharmaceutical formulations from India, the company bridges the gap between international manufacturers and local healthcare providers. Its role is crucial in ensuring that a diverse range of medications is accessible to pharmacies, hospitals, and clinics throughout the country, thereby contributing to the overall health infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Abyak Pharma Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Abyak Pharma Ltd's sourcing strategy is highly concentrated, with a total import value of $3.0 million USD from India over 114 shipments. The company's portfolio is focused on two primary products: caffeine and chlorpheniramine, which together account for 100% of its imports. This single-source dependency may pose risks related to supply chain disruptions, currency fluctuations, and geopolitical factors affecting trade relations. However, the consistent volume of shipments from two verified Indian suppliers—SOCOMED PHARMA PRIVATE LIMITED and XL LABORATORIES PRIVATE LIMITED—suggests a stable and reliable relationship, potentially mitigating some of these risks.

2Supply Chain Resilience

Abyak Pharma Ltd's supply chain resilience is influenced by its reliance on two Indian suppliers for its entire product portfolio. The absence of backup suppliers indicates a potential vulnerability to disruptions such as production delays, regulatory changes, or logistical challenges in India. The company's focus on finished pharmaceutical formulations suggests a preference for ready-to-market products, which may limit its ability to diversify sourcing. Additionally, the shipping routes from India to Ghana are subject to various risks, including port congestion and international trade policies. Ensuring that its suppliers adhere to international Good Manufacturing Practice (GMP) standards is essential for maintaining product quality and compliance with Ghanaian regulations.

Importing Pharmaceuticals into Ghana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ghana

1Regulatory Authority & Framework

The Food and Drugs Authority (FDA) is the national regulatory body responsible for overseeing the safety, efficacy, and quality of pharmaceutical products in Ghana. Established in 1997 under the Food and Drugs Law, 1992 (PNDCL 305B), the FDA operates under the Public Health Act, 2012 (Act 851). Its mandate includes regulating the manufacture, importation, exportation, sale, and distribution of food, drugs, cosmetics, medical devices, and household chemical substances. The FDA's role is critical in safeguarding public health by ensuring that all pharmaceutical products meet established standards before reaching the market. (moh.gov.gh)

2Import Licensing & GMP

To import pharmaceutical products into Ghana, companies must obtain an import license from the FDA. This process involves registering the company and the specific products intended for importation. The FDA requires that all imported pharmaceutical products comply with existing Ghana Standards, which include adherence to Good Manufacturing Practice (GMP) standards recognized by the FDA. Importers must ensure that their products meet these standards to obtain the necessary import permits. (fdaghana.gov.gh)

3Quality & Labeling

Abyak Pharma Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Abyak Pharma Ltd's focus on importing caffeine and chlorpheniramine aligns with the significant demand for respiratory and over-the-counter (OTC) medications, as well as antihistamines and allergy treatments in Ghana. Caffeine is commonly used in various formulations, including pain relievers and stimulants, while chlorpheniramine is a widely used antihistamine for treating allergy symptoms. The company's strategic selection of these products indicates a targeted approach to meet prevalent health concerns in the Ghanaian market.

2Sourcing Profile

Abyak Pharma Ltd's sourcing strategy is centered on importing finished pharmaceutical formulations from India, focusing on specific products like caffeine and chlorpheniramine. This approach suggests a preference for ready-to-market products that meet the FDA's GMP standards. The company's reliance on two Indian suppliers indicates a streamlined procurement process, though it also highlights the need for careful management of supplier relationships to mitigate potential risks associated with supply chain disruptions.

3Market Positioning

By importing and distributing specific pharmaceutical products, Abyak Pharma Ltd serves a niche segment of the Ghanaian market, primarily supplying pharmacies, hospitals, and clinics with essential medications. Its focus on respiratory and OTC products, as well as antihistamines and allergy treatments, positions the company to address common health issues prevalent in the country. This targeted approach enables Abyak Pharma Ltd to cater to the needs of healthcare providers and patients seeking reliable access to these medications.

Seller's Guide — How to Become a Supplier to Abyak Pharma Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Abyak Pharma Ltd, especially those offering high-quality finished pharmaceutical formulations that meet the FDA's GMP standards. The company's existing focus on caffeine and chlorpheniramine suggests potential interest in expanding its product range to include other therapeutic areas. Indian exporters can explore this opportunity by ensuring their products align with the regulatory requirements and quality standards set by the FDA.

2Requirements & Qualifications

Indian exporters seeking to supply Abyak Pharma Ltd and the Ghanaian market must ensure that their products comply with the FDA's GMP standards. Additionally, they must provide certificates of analysis for their products, especially for excipients like glycerin and propylene glycol, testing for impurities such as diethylene glycol and ethylene glycol. Proper labeling, including all required information as specified by the FDA, is also essential. Adhering to these requirements will facilitate the importation process and ensure market acceptance.

3How to Approach

Frequently Asked Questions — Abyak Pharma Ltd

What products does Abyak Pharma Ltd import from India?

Abyak Pharma Ltd imports 2 pharmaceutical products across 2 categories. Top imports: Caffeine ($2.5M), Chlorpheniramine ($497.1K).

Who supplies pharmaceuticals to Abyak Pharma Ltd from India?

Abyak Pharma Ltd sources from 2 verified Indian suppliers. The primary supplier is Socomed Pharma Private Limited (83.6% of imports, $4.2M).

What is Abyak Pharma Ltd's total pharmaceutical import value?

Abyak Pharma Ltd's total pharmaceutical import value from India is $3.0M, based on 114 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Abyak Pharma Ltd focus on?

Abyak Pharma Ltd imports across 2 categories. The largest: Respiratory & OTC (83.3%), Antihistamines & Allergy (16.7%).

Get Full Abyak Pharma Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.